Fulcrum Therapeutics, Inc. (FULC)
3.70
-0.01
(-0.27%)
USD |
NASDAQ |
Oct 06, 09:46
Fulcrum Therapeutics Net Income (Quarterly) : -26.18M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.18M |
| March 31, 2026 | -18.89M |
| December 31, 2025 | -20.33M |
| September 30, 2025 | -19.60M |
| June 30, 2025 | -17.30M |
| March 31, 2025 | -17.66M |
| December 31, 2024 | -16.57M |
| September 30, 2024 | -21.70M |
| June 30, 2024 | 55.41M |
| March 31, 2024 | -26.87M |
| December 31, 2023 | -24.76M |
| September 30, 2023 | -24.02M |
| June 30, 2023 | -23.78M |
| March 31, 2023 | -24.78M |
| December 31, 2022 | -26.14M |
| September 30, 2022 | -23.74M |
| June 30, 2022 | -34.07M |
| Date | Value |
|---|---|
| March 31, 2022 | -25.93M |
| December 31, 2021 | -23.48M |
| September 30, 2021 | -20.72M |
| June 30, 2021 | -19.65M |
| March 31, 2021 | -17.00M |
| December 31, 2020 | -17.72M |
| September 30, 2020 | -18.96M |
| June 30, 2020 | -15.68M |
| March 31, 2020 | -18.45M |
| December 31, 2019 | -16.12M |
| September 30, 2019 | -16.54M |
| June 30, 2019 | -13.17M |
| March 31, 2019 | -36.84M |
| December 31, 2018 | -8.859M |
| September 30, 2018 | -8.943M |
| June 30, 2018 | -7.846M |
| March 31, 2018 | -6.94M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Definium Therapeutics, Inc. | -158.99M |
| LeonaBio, Inc. | -19.01M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 26.18M |
| EPS Diluted (Quarterly) | -0.3433 |
| Enterprise Value | -30.54M |
| Earnings Yield | -32.79% |
| Normalized Earnings Yield | -30.46 |